Variant report

Variant	esv3366700
Chromosome Location	chr6:27218098-27220596
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:539)
CpG islands
(count:427)
Chromatin interactive
region (count:9)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:539 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:27219735-27219758	K562	blood:	n/a	n/a
2	ATF1	chr6:27218754-27219875	K562	blood:	n/a	n/a
3	ATF2	chr6:27219590-27220126	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr6:27218636-27219343	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr6:27218585-27219274	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr6:27219662-27220064	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr6:27219535-27219933	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr6:27219006-27219027	K562	blood:	n/a	n/a
9	BCLAF1	chr6:27218632-27219305	GM12878	blood:	n/a	chr6:27218786-27218799
10	BHLHE40	chr6:27218757-27219992	K562	blood:	n/a	n/a
11	BHLHE40	chr6:27219639-27219870	GM12878	blood:	n/a	n/a
12	BRCA1	chr6:27218365-27218430	H1-hESC	embryonic stem cell:	n/a	n/a
13	BRCA1	chr6:27219556-27219745	H1-hESC	embryonic stem cell:	n/a	n/a
14	BRCA1	chr6:27219589-27219830	Hela-S3	cervix:	n/a	n/a
15	CBX3	chr6:27219489-27220047	K562	blood:	n/a	n/a
16	CBX3	chr6:27218575-27220172	K562	blood:	n/a	n/a
17	CCNT2	chr6:27218837-27219139	K562	blood:	n/a	n/a
18	CCNT2	chr6:27218242-27218582	K562	blood:	n/a	n/a
19	CCNT2	chr6:27219398-27219945	K562	blood:	n/a	n/a
20	CEBPB	chr6:27218831-27219014	K562	blood:	n/a	n/a
21	CEBPB	chr6:27219677-27219989	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr6:27218808-27219082	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr6:27219459-27220092	K562	blood:	n/a	n/a
24	CEBPB	chr6:27219519-27219719	Hela-S3	cervix:	n/a	n/a
25	CHD2	chr6:27218774-27219189	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr6:27219167-27219323	Hela-S3	cervix:	n/a	n/a
27	CHD2	chr6:27219502-27219910	K562	blood:	n/a	n/a
28	CHD2	chr6:27218376-27218407	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr6:27219557-27219966	GM12878	blood:	n/a	n/a
30	CHD2	chr6:27219445-27219980	H1-hESC	embryonic stem cell:	n/a	n/a
31	CHD2	chr6:27218901-27219069	GM12878	blood:	n/a	n/a
32	CHD2	chr6:27219543-27219956	Hela-S3	cervix:	n/a	n/a
33	CREB1	chr6:27219386-27220025	H1-hESC	embryonic stem cell:	n/a	n/a
34	CREB1	chr6:27218655-27219384	H1-hESC	embryonic stem cell:	n/a	n/a
35	CREB1	chr6:27218664-27219268	A549	lung:	n/a	n/a
36	CREB1	chr6:27218720-27219989	GM12878	blood:	n/a	n/a
37	CREB1	chr6:27219401-27220051	H1-hESC	embryonic stem cell:	n/a	n/a
38	CREB1	chr6:27219458-27219915	A549	lung:	n/a	n/a
39	CREB1	chr6:27218621-27219282	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTCF	chr6:27219600-27219750	AG04449	skin:	n/a	n/a
41	CTCF	chr6:27219362-27219936	MCF-7	breast:	n/a	n/a
42	CTCF	chr6:27219560-27219710	GM12873	blood:	n/a	n/a
43	CTCF	chr6:27219720-27219870	WERI-Rb-1	eye:	n/a	n/a
44	CTCF	chr6:27219600-27219750	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr6:27219600-27219750	HPF	lung:	n/a	n/a
46	CTCF	chr6:27219600-27219750	AG09309	skin:	n/a	n/a
47	CTCF	chr6:27219540-27219690	AG09309	skin:	n/a	n/a
48	CTCF	chr6:27219460-27219610	HVMF	connective:	n/a	n/a
49	CTCF	chr6:27219512-27219836	MCF-7	breast:	n/a	n/a
50	CTCF	chr6:27219402-27219904	MCF-7	breast:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:27219317-27219367	ECC-1	luminal epithelium:	n/a
2	chr6:27219983-27220033	AG09309	skin:	n/a
3	chr6:27219317-27219367	PANC-1	pancreas:	n/a
4	chr6:27219812-27219862	HRE	kidney:	n/a
5	chr6:27218966-27219016	IMR90	lung:	fetal
6	chr6:27219317-27219367	HNPCEpiC	eye:	n/a
7	chr6:27219385-27219435	NHBE	bronchial:	n/a
8	chr6:27219983-27220033	ProgFib	skin:	n/a
9	chr6:27219299-27219349	HNPCEpiC	eye:	n/a
10	chr6:27219983-27220033	HRPEpiC	eye:	n/a
11	chr6:27219385-27219435	PFSK-1	brain:	n/a
12	chr6:27219812-27219862	ProgFib	skin:	n/a
13	chr6:27219812-27219862	SKMC	muscle:	n/a
14	chr6:27219299-27219349	Jurkat	blood:	n/a
15	chr6:27219317-27219367	ProgFib	skin:	n/a
16	chr6:27219983-27220033	GM06990	blood:	n/a
17	chr6:27219299-27219349	NT2-D1	testis:	n/a
18	chr6:27219317-27219367	GM12891	blood:	n/a
19	chr6:27218966-27219016	HNPCEpiC	eye:	n/a
20	chr6:27219317-27219367	HIPEpiC	eye:	n/a
21	chr6:27219983-27220033	PANC-1	pancreas:	n/a
22	chr6:27219983-27220033	HEEpiC	esophagus:	n/a
23	chr6:27219299-27219349	NHDF-neo	bronchial:	n/a
24	chr6:27219983-27220033	AG09319	gingival:	n/a
25	chr6:27219983-27220033	AG04450	lung:	fetal
26	chr6:27219385-27219435	ovcar-3	ovarian:	n/a
27	chr6:27219812-27219862	CMK	blood:	n/a
28	chr6:27219385-27219435	SK-N-SH	brain:	n/a
29	chr6:27219983-27220033	AoSMC	blood vessel:	n/a
30	chr6:27218966-27219016	NB4	blood:	n/a
31	chr6:27219983-27220033	HCT-116	colon:	n/a
32	chr6:27218793-27218843	NB4	blood:	n/a
33	chr6:27219385-27219435	HNPCEpiC	eye:	n/a
34	chr6:27218793-27218843	HCF	heart:	n/a
35	chr6:27218966-27219016	PrEC	prostate:	n/a
36	chr6:27219983-27220033	SK-N-SH	brain:	n/a
37	chr6:27219812-27219862	AG10803	skin:	n/a
38	chr6:27218966-27219016	CMK	blood:	n/a
39	chr6:27219317-27219367	GM19239	blood:	n/a
40	chr6:27219983-27220033	RPTEC	kidney:	n/a
41	chr6:27219299-27219349	MCF-7	breast:	n/a
42	chr6:27219299-27219349	IMR90	lung:	fetal
43	chr6:27219299-27219349	T-47D	breast:	n/a
44	chr6:27218793-27218843	SK-N-SH	brain:	n/a
45	chr6:27219812-27219862	A549	lung:	n/a
46	chr6:27219385-27219435	IMR90	lung:	fetal
47	chr6:27219983-27220033	MCF10A-Er-Src	breast:	n/a
48	chr6:27219299-27219349	NHBE	bronchial:	n/a
49	chr6:27219317-27219367	BE2_C	brain:	n/a
50	chr6:27218793-27218843	HRCEpiC	kidney:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:27110323..27115581-chr6:27216717..27220429,5	K562	blood:
2	chr6:26285137..26286889-chr6:27219184..27221854,2	MCF-7	breast:
3	chr6:27217724..27219322-chr6:27799079..27801494,2	MCF-7	breast:
4	chr6:27217680..27220381-chr6:27773874..27775997,2	K562	blood:
5	chr6:27217585..27220597-chr6:27438809..27440860,3	K562	blood:
6	chr6:27111807..27118148-chr6:27215986..27222524,9	K562	blood:
7	chr6:27099473..27102319-chr6:27217669..27219889,2	K562	blood:
8	chr6:27218208..27219861-chr6:27859108..27862899,3	K562	blood:
9	chr1:110576957..110577749-chr6:27219027..27219766,2	HCT-116	colon:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HIST1H2AH-4	chr6:27219101-27219280	NONHSAT108356

No data

Variant related genes	Relation type
PRSS16	TF binding region
PRSS16	CpG island
ENSG00000196747	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000196787	chromatin interactions
ENSG00000143093	chromatin interactions
ENSG00000096654	chromatin interactions
ENSG00000233224	chromatin interactions
ENSG00000217862	chromatin interactions
ENSG00000185130	chromatin interactions
ENSG00000197153	chromatin interactions
ENSG00000196331	chromatin interactions
ENSG00000197914	chromatin interactions
ENSG00000184825	chromatin interactions
ENSG00000158406	chromatin interactions
ENSG00000124635	chromatin interactions
ENSG00000265565	chromatin interactions

Extended variants
information (count: 94 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:94 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113396106	chr6:27218124-27218125	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
2	rs574675030	chr6:27218152-27218153	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
3	rs540337934	chr6:27218153-27218154	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
4	rs560241828	chr6:27218200-27218201	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
5	rs34958997	chr6:27218207-27218208	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
6	rs532030136	chr6:27218303-27218304	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
7	rs375566464	chr6:27218309-27218310	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
8	rs76907775	chr6:27218376-27218377	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
9	rs190928889	chr6:27218385-27218386	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
10	rs532061940	chr6:27218424-27218425	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
11	rs201178324	chr6:27218431-27218432	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
12	rs201197789	chr6:27218445-27218446	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
13	rs369531261	chr6:27218446-27218447	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
14	rs140761256	chr6:27218449-27218450	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
15	rs199948943	chr6:27218457-27218458	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
16	rs35193701	chr6:27218467-27218468	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
17	rs367779428	chr6:27218482-27218483	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
18	rs372674948	chr6:27218485-27218486	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
19	rs35505122	chr6:27218488-27218489	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
20	rs145433670	chr6:27218513-27218514	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
21	rs555888765	chr6:27218613-27218614	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
22	rs547490793	chr6:27218646-27218647	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
23	rs570584427	chr6:27218713-27218714	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
24	rs539466110	chr6:27218772-27218773	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
25	rs182767155	chr6:27218778-27218779	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
26	rs35466700	chr6:27218840-27218841	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
27	rs368386726	chr6:27218858-27218859	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
28	rs199924462	chr6:27218879-27218880	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
29	rs374629730	chr6:27218930-27218931	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
30	rs202204884	chr6:27218956-27218957	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
31	rs201116140	chr6:27218961-27218962	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
32	rs554862324	chr6:27218973-27218974	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
33	rs371550730	chr6:27218974-27218975	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
34	rs376454527	chr6:27218978-27218979	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
35	rs574685427	chr6:27219007-27219008	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
36	rs369039018	chr6:27219014-27219015	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
37	rs200343894	chr6:27219016-27219017	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island Chromatin interactive region	14 gene(s)	Overlapped CNVs	n/a
38	rs13219734	chr6:27219061-27219062	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
39	rs560302630	chr6:27219100-27219101	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
40	rs576902734	chr6:27219133-27219134	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
41	rs567779647	chr6:27219167-27219168	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
42	rs79927166	chr6:27219171-27219172	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
43	rs370479107	chr6:27219182-27219183	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
44	rs531202654	chr6:27219183-27219184	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
45	rs201531272	chr6:27219295-27219296	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	16 gene(s)	Overlapped CNVs	n/a
46	rs548483879	chr6:27219311-27219312	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	16 gene(s)	Overlapped CNVs	n/a
47	rs561998280	chr6:27219323-27219324	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
48	rs527902578	chr6:27219381-27219382	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
49	rs144216233	chr6:27219440-27219441	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
50	rs188756585	chr6:27219455-27219456	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD

Chromatin state (count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27215600-27218800	Bivalent/Poised TSS	Fetal Thymus	thymus
2	chr6:27216000-27218200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:27217600-27218200	Enhancers	K562	blood
4	chr6:27217800-27218400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
5	chr6:27217800-27218600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
6	chr6:27217800-27220200	Active TSS	H1 Cell Line	embryonic stem cell
7	chr6:27218000-27218200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
8	chr6:27218000-27218200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
9	chr6:27218000-27218200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr6:27218000-27218400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr6:27218000-27218400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
12	chr6:27218000-27218400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
13	chr6:27218000-27218400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
14	chr6:27218000-27218400	Enhancers	HMEC	breast
15	chr6:27218000-27218600	Flanking Active TSS	GM12878-XiMat	blood
16	chr6:27218000-27218800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
17	chr6:27218000-27220000	Active TSS	Breast Myoepithelial Primary Cells	Breast
18	chr6:27218000-27220200	Active TSS	H9 Cell Line	embryonic stem cell
19	chr6:27218000-27220200	Bivalent/Poised TSS	Primary T cells from cord blood	blood
20	chr6:27218200-27218400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr6:27218200-27218400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr6:27218200-27218400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr6:27218200-27218400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
24	chr6:27218200-27218400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr6:27218200-27218400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr6:27218200-27218400	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr6:27218200-27218400	Bivalent/Poised TSS	Brain Substantia Nigra	brain
28	chr6:27218200-27218400	Bivalent Enhancer	Fetal Intestine Large	intestine
29	chr6:27218200-27218400	Bivalent Enhancer	Placenta	Placenta
30	chr6:27218200-27218400	Flanking Active TSS	Pancreas	Pancrea
31	chr6:27218200-27218400	Bivalent Enhancer	Stomach Mucosa	stomach
32	chr6:27218200-27218400	Enhancers	NHEK	skin
33	chr6:27218200-27218600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
34	chr6:27218200-27218600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
35	chr6:27218200-27218600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
36	chr6:27218200-27218600	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
37	chr6:27218200-27218600	Flanking Active TSS	K562	blood
38	chr6:27218200-27218800	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
39	chr6:27218200-27219800	Bivalent/Poised TSS	Aorta	Aorta
40	chr6:27218200-27220000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr6:27218200-27220000	Active TSS	A549	lung
42	chr6:27218200-27220200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr6:27218200-27220200	Active TSS	iPS-18 Cell Line	embryonic stem cell
44	chr6:27218200-27220200	Active TSS	Duodenum Mucosa	Duodenum
45	chr6:27218200-27220400	Active TSS	HUES48 Cell Line	embryonic stem cell
46	chr6:27218400-27218600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
47	chr6:27218400-27218600	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr6:27218400-27218600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
49	chr6:27218400-27218600	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
50	chr6:27218400-27218600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links